Tambe said the company, a subsidiary of the Bengaluru-based Biocon Ltd, has five products in the pipeline for launch in the ...

Biocon Biologics CEO discusses revenue growth, market diversification, debt strategy, and impact of US pro-localisation policy.

The Competition Commission of India (CCI) recently imposed a penalty of ₹40 lakh on Goldman Sachs (India) Alternative ...

Biocon Ltd.'s disappointing Q3FY25 performance was largely due to exceptional items, with adjusted net profit standing at Rs 13 crore, and revenue growth of 7% on a like-for-like basis.

Shares of Biocon Ltd closed slightly higher at ₹357.15 on the BSE today, up 0.44% or ₹1.55, ahead of the earnings ...

Paradeep Phosphates has signed a memorandum of understanding with the Odisha government for an investment of Rs 4,000 crore, while Wipro has entered into a five-year, multi-million-dollar contract ...

PORTLAND, IA, UNITED STATES, January 28, 2025 /EINPresswire / -- According to the report, the global biosimilars <a target=_blank href= ...

Today, companies including Religare Enterprises, Gland Pharma, Fortis Malar Hospitals, Aditya Birla Capital, Alembic Pharma, ...

The Competition Commission of India (CCI) recently imposed a penalty of Rs40 lakh on Goldman Sachs (India) Alternative ...